Drugs / Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine
Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01436396 Background | Sep 2011 → Sep 2013 | Dengue hemorrhagic fever, yellow fever | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01436396 ↗ |
| Modality | Vaccine | “Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine” NCT01436396 ↗ |
| Route | Intramuscular | “0.5 mL, intramuscular at age 19 to 20 months” NCT01436396 ↗ |